A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations.
A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations.
复制标题
人源化酵母模型揭示了神经病相关丙氨酰-tRNA 合成酶突变的显性失活特性。
DOI:
10.1093/hmg/ddad054
复制
发表时间:
2023
影响因子:
3.5
通讯作者:
Antonellis,Anthony
中科院分区:
文献类型:
--
作者:
Meyer-Schuman,Rebecca;Marte,Sheila;Smith,TylerJ;Feely,ShawnaME;Kennerson,Marina;Nicholson,Garth;Shy,MikeE;Koutmou,KristinS;Antonellis,Anthony
Aminoacyl-tRNA synthetases (ARSs) are essential enzymes that ligate tRNA molecules to cognate amino acids. Heterozygosity for missense variants or small in-frame deletions in six ARS genes causes dominant axonal peripheral neuropathy. These pathogenic variants reduce enzyme activity without significantly decreasing protein levels and reside in genes encoding homo-dimeric enzymes. These observations raise the possibility that neuropathy-associated ARS variants exert a dominant-negative effect, reducing overall ARS activity below a threshold required for peripheral nerve function. To test such variants for dominant-negative properties, we developed a humanized yeast assay to co-express pathogenic human alanyl-tRNA synthetase (AARS1) mutations with wild-type humanAARS1. We show that multiple loss-of-functionAARS1mutations impair yeast growth through an interaction with wild-typeAARS1, but that reducing this interaction rescues yeast growth. This suggests that neuropathy-associatedAARS1variants exert a dominant-negative effect, which supports a common, loss-of-function mechanism for ARS-mediated dominant peripheral neuropathy.